Galasko D - Search Results

1

Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.

Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E. Crews L, et al. Among authors: galasko d. PLoS One. 2010 Feb 19;5(2):e9313. doi: 10.1371/journal.pone.0009313. PLoS One. 2010. Retraction in: PLoS One. 2024 Nov 13;19(11):e0313935. doi: 10.1371/journal.pone.0313935 PMID: 20174468 Free PMC article. Retracted.

2

Lewy body disease.

Hansen LA, Galasko D. Hansen LA, et al. Among authors: galasko d. Curr Opin Neurol Neurosurg. 1992 Dec;5(6):889-94. Curr Opin Neurol Neurosurg. 1992. PMID: 1467583 Review.

3

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M, et al. Hansen L, et al. Among authors: galasko d. Neurology. 1990 Jan;40(1):1-8. doi: 10.1212/wnl.40.1.1. Neurology. 1990. PMID: 2153271

4

Lobar atrophy with dense-core (brain stem type) Lewy bodies in a patient with dementia.

Masliah E, Galasko D, Wiley CA, Hansen LA. Masliah E, et al. Among authors: galasko d. Acta Neuropathol. 1990;80(4):453-8. doi: 10.1007/BF00307702. Acta Neuropathol. 1990. PMID: 2173332

5

The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease.

Saitoh T, Xia Y, Chen X, Masliah E, Galasko D, Shults C, Thal LJ, Hansen LA, Katzman R. Saitoh T, et al. Among authors: galasko d. Ann Neurol. 1995 Jan;37(1):110-2. doi: 10.1002/ana.410370120. Ann Neurol. 1995. PMID: 7818242

6

Apolipoprotein-E epsilon-4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer's disease.

Hansen LA, Galasko D, Samuel W, Xia Y, Chen X, Saitoh T. Hansen LA, et al. Among authors: galasko d. Neurosci Lett. 1994 Nov 21;182(1):63-5. doi: 10.1016/0304-3940(94)90206-2. Neurosci Lett. 1994. PMID: 7891889

7

The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease.

Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, Hansen L. Galasko D, et al. Neurology. 1994 Oct;44(10):1950-1. doi: 10.1212/wnl.44.10.1950. Neurology. 1994. PMID: 7936253

8

Clinical-neuropathological correlations in Alzheimer's disease and related dementias.

Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill LR, Lessin P, Thal LJ. Galasko D, et al. Arch Neurol. 1994 Sep;51(9):888-95. doi: 10.1001/archneur.1994.00540210060013. Arch Neurol. 1994. PMID: 8080388

9

Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies.

Langlais PJ, Thal L, Hansen L, Galasko D, Alford M, Masliah E. Langlais PJ, et al. Among authors: galasko d. Neurology. 1993 Oct;43(10):1927-34. doi: 10.1212/wnl.43.10.1927. Neurology. 1993. PMID: 8105420

10

Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa.

Hansen LA, Masliah E, Galasko D, Terry RD. Hansen LA, et al. Among authors: galasko d. J Neuropathol Exp Neurol. 1993 Nov;52(6):648-54. doi: 10.1097/00005072-199311000-00012. J Neuropathol Exp Neurol. 1993. PMID: 8229084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

538 results

Search Page

Filters